Principal Financial Group’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.2M | Buy |
1,546,435
+258,314
| +20% | +$4.7M | 0.01% | 666 |
|
|
2025
Q1 | $25.6M | Buy |
1,288,121
+29,107
| +2% | +$577K | 0.01% | 690 |
|
|
2024
Q4 | $21.6M | Buy |
1,259,014
+64,793
| +5% | +$1.11M | 0.01% | 814 |
|
|
2024
Q3 | $23.9M | Buy |
1,194,221
+1,059,394
| +786% | +$21.2M | 0.01% | 749 |
|
|
2024
Q2 | $1.51M | Sell |
134,827
-1,433
| -1% | -$16K | ﹤0.01% | 1807 |
|
|
2024
Q1 | $899K | Sell |
136,260
-22,374
| -14% | -$148K | ﹤0.01% | 1880 |
|
|
2023
Q4 | $717K | Buy |
158,634
+23,844
| +18% | +$108K | ﹤0.01% | 1884 |
|
|
2023
Q3 | $483K | Buy |
134,790
+30,088
| +29% | +$108K | ﹤0.01% | 1961 |
|
|
2023
Q2 | $386K | Buy |
104,702
+2,225
| +2% | +$8.21K | ﹤0.01% | 2008 |
|
|
2023
Q1 | $339K | Sell |
102,477
-6,673
| -6% | -$22.1K | ﹤0.01% | 2059 |
|
|
2022
Q4 | $424K | Buy |
109,150
+29,362
| +37% | +$114K | ﹤0.01% | 2015 |
|
|
2022
Q3 | $194K | Sell |
79,788
-54,586
| -41% | -$133K | ﹤0.01% | 2212 |
|
|
2022
Q2 | $266K | Buy |
134,374
+119,333
| +793% | +$236K | ﹤0.01% | 2218 |
|
|
2022
Q1 | $28K | Sell |
15,041
-847
| -5% | -$1.58K | ﹤0.01% | 2512 |
|
|
2021
Q4 | $22K | Sell |
15,888
-2,896
| -15% | -$4.01K | ﹤0.01% | 2509 |
|
|
2021
Q3 | $21K | Sell |
18,784
-3,043
| -14% | -$3.4K | ﹤0.01% | 2569 |
|
|
2021
Q2 | $35K | Sell |
21,827
-338,684
| -94% | -$543K | ﹤0.01% | 2591 |
|
|
2021
Q1 | $634K | Buy |
360,511
+24,953
| +7% | +$43.9K | ﹤0.01% | 2088 |
|
|
2020
Q4 | $655K | Buy |
335,558
+193,338
| +136% | +$377K | ﹤0.01% | 2039 |
|
|
2020
Q3 | $340K | Buy |
142,220
+58,428
| +70% | +$140K | ﹤0.01% | 2104 |
|
|
2020
Q2 | $246K | Buy |
+83,792
| New | +$246K | ﹤0.01% | 2135 |
|